BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-19 out of 19 found
  Current Search:  lamivudine: 19     

HTML
100%
Lopinavir/ritonavir Monotherapy or Plus Zidovudine and Lamivudine in Antiretroviral-naive HIV-infected Patient
_ Lopinavir/ritonavir Monotherapy or Plus Zidovudine and Lamivudine in Antiretroviral-naive HIV-infected Patient.
AIDS:  Jul 2 2008 9:19PM
Matching: lamivudine
Find similar documents
HTML
100%
Entecavir Boosts Hepatitis B Response After Lamivudine Failure
TORONTO, July 1 -- Patients who were lamivudine (Epivir) refractory saw improved hepatitis B suppression that lasted through almost two years of treatment with entecavir (Baraclude).

The percentage of patients with fewer than 300 HBV DNA...

MedPage Today:  Jul 1 2008 5:21PM
Matching: lamivudine
Find similar documents
HTML
100%
Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine
_ Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine.
Abstracts in Hematology and Oncology:  Jul 1 2008 2:43AM
Matching: lamivudine
Find similar documents
HTML
100%
Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine
_ Entecavir May Be Effective for Hepatitis B Refractory to Lamivudine.
Medscape:  Jun 30 2008 8:22PM
Matching: lamivudine
Find similar documents
HTML
100%
Safer, better medication for Hepatitis B identified
Washington, June 27 : Hepatitis B patients who didn't respond to the common treatment of lamivudine might get better and safer results with another drug called entecavir, a new study has found.

Chronic Hepatitis B is the 10th leading cause...

NewKerala.com:  Jun 28 2008 12:55PM
Matching: lamivudine
Find similar documents
HTML
100%
Study touts entecavir drug as safer, more efficient medication for Hepatitis B
Researchers from Toronto General Hospital have found a new safer, more efficient medication for Hepatitis B for patients who don't respond to other medications.

During the study Morris Sherman and colleagues found that patients with...

NetIndia123.com:  Jun 28 2008 10:53AM
Matching: lamivudine
Find similar documents
HTML
100%
Safer, better medication for Hepatitis B identified
Hepatitis B patients who didn't respond to the common treatment of lamivudine might get better and safer results with another drug called entecavir, a new study has found.Chronic Hepatitis B is the 10th leading cause of death worldwide.
NetIndia123.com:  Jun 28 2008 10:51AM
Matching: lamivudine
Find similar documents
HTML
100%
Entecavir Safe, Effective in Patients Unresponsive to Lamivudine
my personal edition> hepatitis other > news E-Mail this DGNews to a colleague DGNews MALDEN, Mass -- June 27, 2008 -- Patients with hepatitis B virus (HBV) who did not respond to lamivudine therapy had a better virological...
Doctors Guide:  Jun 28 2008 1:30AM
Matching: lamivudine
Find similar documents
HTML
100%
Entecavir Safe, Effective in Patients Unresponsive to Lamivudine
-- Patients with hepatitis B virus (HBV) who did not respond to lamivudine therapy had a better virological response after switching to entecavir for 1 year, according to a new study in the July issue of Hepatology.

Continuing the drug for...

PSL Group:  Jun 28 2008 1:13AM
Matching: lamivudine
Find similar documents
HTML
100%
Study touts entecavir drug as safer, more efficient medication for Hepatitis B
Study touts entecavir drug as safer, more efficient medication for Hepatitis BWashington June 27, 2008 11:50:26 AM IST Researchers from Toronto General Hospital have found a new safer, more efficient medication for Hepatitis B for patients...
Webindia123:  Jun 27 2008 10:17PM
Matching: lamivudine
Find similar documents
HTML
100%
Safer, better medication for Hepatitis B identified
Safer, better medication for Hepatitis B identifiedWashington June 27, 2008 4:35:09 PM IST Hepatitis B patients who didn't respond to the common treatment of lamivudine might get better and safer results with another drug called entecavir, a...
Webindia123:  Jun 27 2008 10:16PM
Matching: lamivudine
Find similar documents
HTML
100%
Safer, better medication for Hepatitis B identified
Washington: Hepatitis B patients who didn't respond to the common treatment of lamivudine might get better and safer results with another drug called entecavir, a new study has found.

Chronic Hepatitis B is the 10th leading cause of death...

Sify:  Jun 27 2008 8:38PM
Matching: lamivudine
Find similar documents
HTML
100%
Safer, more efficient medication for hepatitis B treatment
Chronic hepatitis B is the tenth leading cause of death worldwide.

Infected patients are at high risk of developing serious liver diseases such as cirrhosis and liver cancer, especially if they have high levels of HBV DNA in their blood.

Huliq.com:  Jun 27 2008 1:50PM
Matching: lamivudine
Find similar documents
HTML
100%
Safer, More Efficient Medication For Hepatitis B Treatment Found
Patients with hepatitis B who did not respond to lamivudine therapy had a better virological response after switching to entecavir for a year.

Continuing the drug for an additional year led to even more clinical improvement without...

Science Daily:  Jun 27 2008 6:46AM
Matching: lamivudine
Find similar documents
HTML
100%
Study finds safer, more efficient medication for hepatitis B treatment
, 3:45 PM EST Patients with hepatitis B who did not respond to lamivudine therapy had a better virological response after switching to entecavir for a year.

Continuing the drug for an additional year led to even more clinical improvement...

Genetic Engineering News:  Jun 26 2008 9:05PM
Matching: lamivudine
Find similar documents
HTML
100%
NICE Issues Final Appraisal Determination (FAD) Which Recommends Baraclude(R) (Entecavir) as a Treatment Optio
NICE (National Institute for Health and Clinical Excellence) has announced today, in its Final Appraisal Determination (FAD), that Baraclude(R) (entecavir) is recommended as an option for treatment of eligible patients with chronic hepatitis...
Macro World Investor:  Jun 24 2008 11:05PM
Matching: lamivudine
Find similar documents
HTML
100%
FDA Announces Tentative Approval: Fixed Dose Combination of Generic Lamivudine/Stavudine Tablets for Pediatric
FDA granted tentative approval to fixed dose combination lamivudine/stavudine tablets, 30mg/6mg & 60mg/12mg for oral suspension for pediatric use, manufactured by Cipla Limited of Mumbai, India.

The application was reviewed under...

Pharma Live:  Jun 20 2008 7:01PM
Matching: lamivudine
Find similar documents
HTML
100%
Antiretroviral Therapy in Adults
Objective To update recommendations for antiretroviral therapy for adult human immunodeficiency virus type 1 (HIV-1) infection, based on new information and drugs that are available.

Participants A 17-member international physician panel...

Journal of the American Medical Association:  Jun 4 2008 11:03PM
Matching: lamivudine
Find similar documents
HTML
100%
Understanding Resistance in Hepatitis B -- Clinical Implications
Recent estimates suggest that worldwide, 2 billion people have been infected with hepatitis B virus (HBV), with more than 360 million individuals chronically infected and at substantial risk for major complications (most notably,...
Medscape:  May 31 2008 9:30AM
Matching: lamivudine
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.